We found that AJCC stage, differentiation, lymph node metastasis PSA, and Gleason score were all significantly correlated with DSCAM-AS1, but only AJCC and PSA were found to be predictive markers of prognostic risk factors. This evidence concerns the gene DSCAM and metastatic malignant neoplasm in the lymph nodes.